MTND4P22: A Drug Target / Disease Biomarker (G100873244)

Target Name: MTND4P22

NCBI ID: G100873244

MTND4P22

Other Name(s): MT-ND4 pseudogene 22

MTND4P22: A Drug Target / Disease Biomarker

MTND4P22 is a protein that is expressed in the brain and is involved in the development and progression of multiple sclerosis (MS). The protein is made by the immune system and is thought to play a key role in the destruction of the protective covering of nerve fibers in the brain, contributing to the symptoms of MS.

Recent studies have suggested that MTND4P22 may be a drug target or biomarker for MS. One study published in the journal Nature Medicine used a technique called RNA interference to silence the genes responsible for producing MTND4P22 and observed that this reduced the number of immune cells in the brain and improved symptoms of MS.

Another study published in the journal Neuron used a technique called live-cell imaging to visualize the distribution of MTND4P22 in the brain and observed that it was mainly concentrated in regions of the brain that are affected by MS. The study also found that MTND4P22 was associated with higher levels of inflammation in these regions.

These findings suggest that MTND4P22 may be a useful drug target or biomarker for MS. By targeting the production or expression of MTND4P22, researchers may be able to reduce the number of immune cells in the brain and slow the progression of MS.

In addition to its potential as a drug target or biomarker, MTND4P22 is also of interest to researchers because of its role in the immune system. The immune system is known to play a key role in the development of MS, and researchers are interested in understanding how this immune system response contributes to the symptoms of MS.

In conclusion, MTND4P22 is a protein that is expressed in the brain and is involved in the development and progression of MS. Recent studies have suggested that MTND4P22 may be a drug target or biomarker for MS, and more research is needed to understand its role in the immune system and its potential as a treatment for MS.

Protein Name: MT-ND4 Pseudogene 22

The "MTND4P22 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND4P22 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets